Boothbay Fund Management, LLC Neuronetics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.28 Billion
- Q1 2025
A detailed history of Boothbay Fund Management, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 347,228 shares of STIM stock, worth $1.19 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
347,228Holding current value
$1.19 Million% of portfolio
0.04%Shares
8 transactions
Others Institutions Holding STIM
# of Institutions
109Shares Held
19.5MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$7.93 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$5.98 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$4.87 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$3.78 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.44 Million0.19% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $93M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...